Please note all event times are Eastern Standard Time (EST)
Have you been diagnosed with blood clots?
After experiencing a blood clot, it’s normal to have a lot of questions. Many people are left feeling confused about why this happened to them and anxious about it happening again. NATF is here to be your support system.
Support groups can be very beneficial to patients. NATF’s Blood Clot support groups allow patients to:
- Find accurate information about blood clots
- Share with others first-hand experiences
- Help one another cope with the physical and psychological challenges of a clot
We’re pleased to offer a virtual support group experience where patients can share their stories, connect with others who have had blood clots, and receive emotional support. This group is hosted by Joelle Hochman, RRT, NATF’s Chair of Patient Engagement & Education.
A clinician will also be available in each support group to answer general questions about blood clots. Please note that our clinician guests cannot provide personalized medical advice.
This month, we will be joined by Dr. Nathan Connell!
Dr. Nathan Connell is Chief of Medicine at Brigham and Women’s Faulkner Hospital, Vice Chair for BWFH Clinical Services & Education in the Department of Medicine at Brigham and Women’s Hospital, Associate Director of the Boston Hemophilia Center, and Associate Professor of Medicine at Harvard Medical School.
His clinical practice focuses on disorders of thrombosis and hemostasis, with interest in the spectrum of clinical disorders related to the coagulation protein von Willebrand factor. In addition to his clinical practice within the Boston Hemophilia Center, he researches cost-effective strategies for diagnosis and management of hematologic disorders. A graduate of Cornell University, the University of Miami School of Medicine, and the Harvard School of Public Health, he completed internal medicine residency and hematology/oncology fellowship at Brown University. He is active with the American Society of Hematology, where he helped define and develop the field of systems-based hematology, which works to optimize care delivery systems for patients with blood disorders and he co-chaired the ASH ISTH NHF WFH Guidelines on the Diagnosis and Management of von Willebrand disease.
He chairs the Steering Committee of the National Heart, Lung, and Blood Institute (NHLBI)-sponsored ATTRACT Trial of DVT treatment. Dr. Goldhaber is a member of the Steering Committee and is the U.S. National Coordinator of the GARFIELD Atrial Fibrillation cohort study and the GARFIELD Venous Thromboembolism cohort study. He is a Section Editor for Circulation and for Thrombosis and Haemostasis. He also has a busy practice of general cardiology, venous thromboembolism, and atrial fibrillation patients.